World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
49
Citations
9776
World Ranking
4328
National Ranking
1968

Agustin Calatroni publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Agustin Calatroni sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 160 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Agustin Calatroni D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Agustin Calatroni sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 49 D-Index — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Agustin Calatroni is a researcher affiliated with Rho Federal Systems in the United States, specializing in the field of Medicine. Their work primarily spans several subfields including Physiology, Immunology and Allergy, Pulmonary and Respiratory Medicine, Dermatology, and Health, Toxicology and Mutagenesis.

Their research focuses on key topics related to respiratory and allergic conditions as well as dermatological issues. These topics include:

  • Asthma and respiratory diseases
  • Allergic Rhinitis and Sensitization
  • Dermatology and Skin Diseases
  • Pediatric health and respiratory diseases
  • Food Allergy and Anaphylaxis Research
  • IL-33, ST2, and ILC Pathways
  • Noise Effects and Management

Calatroni has published extensively, with notable recent papers that include:

  • Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial (2021, Nature Medicine)
  • Omalizumab for the Treatment of Multiple Food Allergies (2024, New England Journal of Medicine)
  • Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial (2022, The Lancet)
  • Childhood Asthma Incidence, Early and Persistent Wheeze, and Neighborhood Socioeconomic Factors in the ECHO/CREW Consortium (2022, JAMA Pediatrics)
  • Associations between outdoor air pollutants and non-viral asthma exacerbations and airway inflammatory responses in children and adolescents living in urban areas in the USA: a retrospective secondary analysis (2023, The Lancet Planetary Health)

Their frequent co-authors reflect continued collaborations with experts in related fields, including:

  • Leonard B. Bacharier
  • Daniel J. Jackson
  • George O'connor
  • James E. Gern
  • Gurjit K. Khurana Hershey

Calatroni's work is commonly published in specialized venues focused on allergy and immunology. The most frequent publication outlets include:

  • Journal of Allergy and Clinical Immunology
  • The Journal of Allergy and Clinical Immunology In Practice
  • SSRN Electronic Journal
  • UNC Libraries
  • JAMA Pediatrics

Best Publications

  • Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

    William W. Busse;Wayne J. Morgan;Peter J. Gergen;Herman E. Mitchell

  • Randomized Trial of Omalizumab (Anti-IgE) for Asthma in Inner-City Children

    William W. Busse;Wayne J. Morgan;Peter J. Gergen;Herman E. Mitchell

  • Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations.

    Stephen J. Teach;Michelle A. Gill;Alkis Togias;Christine A. Sorkness

  • Effects of early-life exposure to allergens and bacteria on recurrent wheeze and atopy in urban children

    Susan V. Lynch;Robert A. Wood;Homer Boushey;Leonard B. Bacharier

  • Prevalence of allergic sensitization in the United States: results from the National Health and Nutrition Examination Survey (NHANES) 2005-2006.

    Päivi M. Salo;Samuel J. Arbes;Renee Jaramillo;Agustin Calatroni

  • Association of obesity with IgE levels and allergy symptoms in children and adolescents: results from the National Health and Nutrition Examination Survey 2005-2006.

    Cynthia M. Visness;Stephanie J. London;Julie L. Daniels;Jay S. Kaufman

  • Development of a human skin commensal microbe for bacteriotherapy of atopic dermatitis and use in a phase 1 randomized clinical trial.

    Teruaki Nakatsuji;Tissa R. Hata;Yun Tong;Joyce Y. Cheng

  • Allergy-related outcomes in relation to serum IgE: Results from the National Health and Nutrition Examination Survey 2005-2006

    Päivi M. Salo;Agustin Calatroni;Peter J. Gergen;Jane A. Hoppin

  • Effects of Omalizumab on Rhinovirus Infections, Illnesses, and Exacerbations of Asthma.

    Ann Esquivel;William W. Busse;Agustin Calatroni;Alkis G. Togias

  • Prenatal maternal stress and cord blood innate and adaptive cytokine responses in an inner-city cohort.

    Rosalind J. Wright;Cynthia M. Visness;Agustin Calatroni;Mitchell H. Grayson

  • Omalizumab for the Treatment of Multiple Food Allergies.

    Unknown

  • Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005-2006.

    Peter J. Gergen;Samuel J. Arbes;Agustin Calatroni;Herman E. Mitchell

  • Association of Childhood Obesity With Atopic and Nonatopic Asthma: Results From the National Health and Nutrition Examination Survey 1999-2006

    Cynthia M. Visness;P.H. Stephanie J. London;Julie L. Daniels;Jay S. Kaufman;Jay S. Kaufman

  • DNA methylation and childhood asthma in the inner city.

    Ivana V. Yang;Brent S. Pedersen;Andrew Liu;George T. O'Connor

  • Asthma control, adiposity, and adipokines among inner-city adolescents.

    Meyer Kattan;Rajesh Kumar;Gordon R. Bloomberg;Herman E. Mitchell

  • Early-life home environment and risk of asthma among inner-city children.

    George T. O'Connor;Susan V. Lynch;Gordon R. Bloomberg;Meyer Kattan

  • The nonlesional skin surface distinguishes atopic dermatitis with food allergy as a unique endotype

    Donald Y. M. Leung;Agustin Calatroni;Livia S. Zaramela;Petra K. LeBeau

  • Enhanced plasmacytoid dendritic cell antiviral responses after omalizumab

    Michelle A. Gill;Andrew H. Liu;Agustin Calatroni;Rebecca Z. Krouse

  • Seasonal risk factors for asthma exacerbations among inner-city children.

    Stephen J. Teach;Peter J. Gergen;Stanley J. Szefler;Herman E. Mitchell

  • Mepolizumab for urban children with exacerbation-prone eosinophilic asthma in the USA (MUPPITS-2): a randomised, double-blind, placebo-controlled, parallel-group trial

    Unknown

  • Development and Validation of the Composite Asthma Severity Index – An Outcome Measure for use in Children and Adolescents

    Jeremy J. Wildfire;Peter J. Gergen;Christine A. Sorkness;Herman E. Mitchell

  • Evidence of pathway‐specific basophil anergy induced by peanut oral immunotherapy in peanut‐allergic children

    Ananth Thyagarajan;Stacie M. Jones;Agustin Calatroni;Laurent Pons

  • Iconographies supplémentaires de l'article : Allergy-related outcomes in relation to serum IgE: Results from the National Health and Nutrition Examination Survey 2005-2006

    Päivi M Salo;Agustin Calatroni;Peter J Gergen;Jane A Hoppin

Frequent Co-Authors

Peter J. Gergen
Peter J. Gergen National Institute of Allergy and Infectious Diseases
Meyer Kattan
Meyer Kattan Columbia University
James E. Gern
James E. Gern University of Wisconsin–Madison
Robert A. Wood
Robert A. Wood Johns Hopkins University School of Medicine
Andrew H. Liu
Andrew H. Liu University of Colorado Denver
Herman Mitchell
Herman Mitchell National Institutes of Health
George T. O'Connor
George T. O'Connor Boston University
William W. Busse
William W. Busse University of Wisconsin–Madison
Darryl C. Zeldin
Darryl C. Zeldin National Institutes of Health
Rebecca S. Gruchalla
Rebecca S. Gruchalla The University of Texas Southwestern Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology but seeking flexible education options, exploring nursing pathways can be a practical choice. Many professionals pivot to healthcare roles through programs designed for non-traditional students. If you're new to nursing, the best online rn programs for non nurses offer accessible routes to enter this vital field.

Accelerated degree options also allow faster completion for those committed to advancing their careers quickly. You might consider 12-month accelerated nursing programs, which streamline education without sacrificing quality, ideal for driven individuals.

If you prefer starting with foundational qualifications, exploring which lpn programs are easiest to get into can offer insight into practical nursing roles that support immunological research and patient care.

For advanced practice and greater autonomy, review options for which nurse practitioner program is easiest. These programs provide specialized training that can intersect with immunology-focused healthcare delivery.

By leveraging these educational pathways, students and professionals can enhance their expertise and expand career opportunities within the immunology landscape.

Best Scientists Citing Agustin Calatroni

Trending Scientists